Episode Synopsis "5. CECOG - Fireside Chats - Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatment"

Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatmentHost: Doz. Dr. Christiane ThallingerUniv. Prof. Dr. Evandro De AzambujaInstitut Jules BordetBelgiumUniv. Prof. Dr. Christoph ZielinskiProfessor of Medical Oncology and Clinical ImmunologyMedical Director, Wiener Privatklinik and Central European Cancer CenterWien, AustriaPresident, Central European Cooperative Oncology Group (CECOG)Editor in Chief, "ESMO Open - Cancer Horizons", 2016-2021

Listen "5. CECOG - Fireside Chats - Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatment"

More episodes of the podcast CECOG Academy Podcasts

• Genetic Consenting Training Programme - Module 13
• Genetic Consenting Training Programme - Module 12
• Genetic Consenting Training Programme - Module 11
• Genetic Consenting Training Programme - Module 10
• Genetic Consenting Training Programme - Module 9
• Genetic Consenting Training Programme - Module 8
• Genetic Consenting Training Programme - Module 7
• Genetic Consenting Training Programme - Module 6
• Genetic Consenting Training Programme - Module 5
• Genetic Consenting Training Programme - Module 4
• Genetic Consenting Training Programme - Module 3
• Genetic Consenting Training Programme - Module 2
• Genetic Consenting Training Programme - Module 1
• 6. CECOG - Fireside Chats - Targeted treatment options to improve outcomes in EGFRm NSCLC
• 5. CECOG - Fireside Chats - Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatment
• 4. CECOG - Fireside Chats - Clinical implementation of immuno-oncology therapy in unresectable stage III NSCLC
• 3. CECOG - Fireside Chats - How new treatments are impacting the work of Multidisciplinary Teams (MTD) (incl guidelines discussion)
• 2. CECOG - Fireside Chats - Changing the ES-SCLC Paradigm with Immuno-Oncology Combinations
• 1. CECOG - Fireside Chats - Patient needs in later lines of mBC (testing, efficacy of current treatment – what do we need)
• CECOG - "PANCREAS CANCER ACADEMY 2020 - Panel discussion: Advocates only"
• CECOG - "PANCREAS CANCER ACADEMY 2020"
• CECOG - "TIGER & LEOPARD"
• CECOG - "The Cancer Dashboard for Central and Southeastern Europe"
• CECOG - "Who we are and what we do"